Z-1542-2018 Class III Terminated
FDA device recall Z-1542-2018 was initiated by Ameditech Inc on Dec 15, 2017 and is designated Class III. Reason for recall: The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box. The recall status is terminated (terminated Feb 11, 2019). Affected quantity: 828 kits (20,700 devices).
Recall details
- Product Type
- Devices
- Report Date
- May 9, 2018
- Initiation Date
- Dec 15, 2017
- Termination Date
- Feb 11, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 828 kits (20,700 devices)
Product description
Alere iScreen Dx Urine Drug Screen Card
Reason for recall
The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box.
Distribution pattern
Distributed domestically to AZ, FL, IL, ND, NV, PA, TN, TX, VA.
Code information
Part No. X11-IS10-Dx, Lot No. 173351, 173686, 174055, 176002.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1542-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026